176 related articles for article (PubMed ID: 33560720)
1. Correlation between semiquantitative and volumetric 18F-FDG PET/computed tomography parameters and Ki-67 expression in breast cancer.
Mohamadien NRA; Sayed MHM
Nucl Med Commun; 2021 Jun; 42(6):656-664. PubMed ID: 33560720
[TBL] [Abstract][Full Text] [Related]
2. Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.
Kitao T; Shiga T; Hirata K; Sekizawa M; Takei T; Yamashiro K; Tamaki N
Ann Nucl Med; 2019 Jan; 33(1):22-31. PubMed ID: 30196378
[TBL] [Abstract][Full Text] [Related]
3. The correlation of
Qu YH; Long N; Ran C; Sun J
Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Tumor Burden Assessed by Dual Time Point [
Garcia-Vicente AM; Pérez-Beteta J; Pérez-García VM; Molina D; Jiménez-Londoño GA; Soriano-Castrejón A; Martínez-González A
Mol Imaging Biol; 2017 Aug; 19(4):636-644. PubMed ID: 27981471
[TBL] [Abstract][Full Text] [Related]
5. Correlation between
Zhao J; Wang H
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):188-194. PubMed ID: 33538120
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
[TBL] [Abstract][Full Text] [Related]
7. Correlation of
Mayoral M; Paredes P; Saco A; Fusté P; Perlaza P; Tapias A; Fernandez-Martinez A; Vidal L; Ordi J; Pavia J; Martinez-Roman S; Lomeña F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(2):80-86. PubMed ID: 28869177
[TBL] [Abstract][Full Text] [Related]
8. [The relationship between (18)F-FDG PET/CT metabolic parameters and clinicopathological features of breast cancer].
Tang B; Zhang Y; Zhou J; Xu Y; Li TR; Ding CY
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):280-285. PubMed ID: 28550668
[No Abstract] [Full Text] [Related]
9. Alternative volumetric PET pjmirometers for evaluation of breast cancer cases with 18F-FDG PET/CT imaging: Metabolic tumour volume and total lesion glycolysis.
Arslan E; Can Trabulus D; Mermut Ö; Şavlı TC; Çermik TF
J Med Imaging Radiat Oncol; 2021 Feb; 65(1):38-45. PubMed ID: 33084216
[TBL] [Abstract][Full Text] [Related]
10. The correlation of prognostic biomarkers (Ki-67, Bcl-2, HIF-1α, cyclin D1) with metabolic tumor volume measured by F-FDG PET/CT inlaryngeal cancer.
Eryilmaz A; Cengiz A; Basal Y; Meteoglu I; Omurlu IK; Yurekli Y
J Cancer Res Ther; 2018; 14(5):994-998. PubMed ID: 30197337
[TBL] [Abstract][Full Text] [Related]
11. Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study.
Linguanti F; Abenavoli EM; Briganti V; Danti G; Lavacchi D; Matteini M; Vaggelli L; Novelli L; Grosso AM; Mungai F; Mini E; Antonuzzo L; Miele V; Sciagrà R; Berti V
Ann Nucl Med; 2023 Jan; 37(1):1-9. PubMed ID: 36309948
[TBL] [Abstract][Full Text] [Related]
12. Assessment of biological and clinical aggressiveness of invasive ductal breast cancer using baseline 18F-FDG PET/CT-derived volumetric parameters.
Ege Aktas G; Taştekin E; Sarikaya A
Nucl Med Commun; 2018 Jan; 39(1):83-93. PubMed ID: 29135722
[TBL] [Abstract][Full Text] [Related]
13. Relationship between 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters and clinicopathology in endometrial cancer.
Yao X; Tan X; Zhang H; Yuan H; Zeng B; He L; Jiang L
Nucl Med Commun; 2022 Dec; 43(12):1233-1238. PubMed ID: 36345768
[TBL] [Abstract][Full Text] [Related]
14. Association between semiquantitative PET parameters and molecular subtypes of breast invasive ductal carcinoma.
Chiacchio S; Evangelista L; Alsharif A; Manca G; DI Martino F; Negri A; Tredici M; Cervino AR; Puccini G; Filidei E; Ghilli M; Naccarato AG; Roncella M; Volterrani D
Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):101-111. PubMed ID: 26329496
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of FDG-PET and DWI in breast cancer.
Kitajima K; Miyoshi Y; Yamano T; Odawara S; Higuchi T; Yamakado K
Ann Nucl Med; 2018 Jan; 32(1):44-53. PubMed ID: 29134565
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Surgically Treated Stage I Lung Adenocarcinoma Patients.
Tosi D; Pieropan S; Cattoni M; Bonitta G; Franzi S; Mendogni P; Imperatori A; Rotolo N; Castellani M; Cuzzocrea M; Schiorlin I; Casagrande S; De Palma D; Nosotti M; Dominioni L
Clin Nucl Med; 2021 Aug; 46(8):621-626. PubMed ID: 34034316
[TBL] [Abstract][Full Text] [Related]
17. Value of metabolic parameters of primary lesions examined by 18F-FDG PET/CT for endometrial cancer in preoperative evaluation.
Gai QZ; Lv YB; Li GY; Zhang DQ; Gao Z; Fang XH
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2493-2502. PubMed ID: 33829435
[TBL] [Abstract][Full Text] [Related]
18. Characterization of sacral chordoma and differential diagnosis from other sacral malignancy using [18F]FDG PET/CT.
Lee DY; Kim YI; Ryu JS; Kim W
Medicine (Baltimore); 2024 Apr; 103(14):e37678. PubMed ID: 38579025
[TBL] [Abstract][Full Text] [Related]
19. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
Deantonio L; Caroli A; Puta E; Ferrante D; Apicella F; Turri L; Sacchetti G; Brambilla M; Krengli M
Radiat Oncol; 2018 Oct; 13(1):211. PubMed ID: 30359275
[TBL] [Abstract][Full Text] [Related]
20. Volume-based metabolic parameter of breast cancer on preoperative 18F-FDG PET/CT could predict axillary lymph node metastasis.
An YS; Kang DK; Jung Y; Kim TH
Medicine (Baltimore); 2017 Nov; 96(45):e8557. PubMed ID: 29137072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]